全文获取类型
收费全文 | 2505篇 |
免费 | 168篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 32篇 |
妇产科学 | 67篇 |
基础医学 | 335篇 |
口腔科学 | 29篇 |
临床医学 | 252篇 |
内科学 | 524篇 |
皮肤病学 | 10篇 |
神经病学 | 153篇 |
特种医学 | 61篇 |
外科学 | 356篇 |
综合类 | 20篇 |
预防医学 | 254篇 |
眼科学 | 138篇 |
药学 | 254篇 |
中国医学 | 3篇 |
肿瘤学 | 140篇 |
出版年
2021年 | 65篇 |
2020年 | 22篇 |
2019年 | 49篇 |
2018年 | 53篇 |
2017年 | 35篇 |
2016年 | 54篇 |
2015年 | 45篇 |
2014年 | 70篇 |
2013年 | 114篇 |
2012年 | 124篇 |
2011年 | 148篇 |
2010年 | 86篇 |
2009年 | 85篇 |
2008年 | 119篇 |
2007年 | 137篇 |
2006年 | 136篇 |
2005年 | 135篇 |
2004年 | 126篇 |
2003年 | 140篇 |
2002年 | 121篇 |
2001年 | 45篇 |
2000年 | 39篇 |
1999年 | 44篇 |
1998年 | 23篇 |
1997年 | 40篇 |
1996年 | 31篇 |
1995年 | 21篇 |
1994年 | 26篇 |
1993年 | 25篇 |
1992年 | 25篇 |
1991年 | 22篇 |
1990年 | 25篇 |
1989年 | 21篇 |
1988年 | 14篇 |
1987年 | 15篇 |
1986年 | 25篇 |
1985年 | 17篇 |
1984年 | 24篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 21篇 |
1980年 | 20篇 |
1979年 | 16篇 |
1978年 | 17篇 |
1977年 | 20篇 |
1976年 | 16篇 |
1975年 | 29篇 |
1974年 | 17篇 |
1968年 | 14篇 |
1967年 | 13篇 |
排序方式: 共有2682条查询结果,搜索用时 15 毫秒
1.
2.
Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia 总被引:2,自引:0,他引:2
Hyperreflexia is the most common urological finding in patients with multiple sclerosis. A prospective randomized study was done to compare the effectiveness of 2 commonly used drugs, oxybutynin and propantheline. Of the 34 patients entered into the trial 19 were treated with oxybutynin and 15 with propantheline. The urological symptoms (frequency, nocturia, hesitancy, urgency and urge incontinence) were graded according to severity from 0 to 3. Patients with urinary infection were excluded. Urodynamic examination, consisting of cystometrography and electromyography, was performed in all patients before treatment. Both groups of patients had comparable neurological, urological and urodynamic status before treatment. In 4 patients (21 per cent) treated with oxybutynin and in 4 (27 per cent) treated with propantheline side effects were so severe that the treatment had to be discontinued. Symptomatic response to oxybutynin was good in 10 patients (67 per cent), fair in 2 (13 per cent) and poor in 3 (20 per cent). Propantheline produced good symptomatic results in 4 patients (36 per cent), fair in 1 (9 per cent) and poor in 6 (55 per cent). The mean increase in maximum cystometric capacity on cystometrography was significantly larger in the oxybutynin group than in the propantheline group (144 +/- 115 versus 35 +/- 101). Our results indicate that oxybutynin is more effective than propantheline in the treatment of detrusor hyperreflexia in patients with multiple sclerosis. 相似文献
3.
4.
α-Methylene-γ-butyrolactones with Molluscicidal Activity The α-methylene-γ-butyrolactones 1-28 were tested in vitro for molluscicidal activity against Biomphalaria glabrata. The racemic compound 25 shows the best activity. The synthesis was carried out by modified Reformatzky reaction of the corresponding carbonyl compounds and bromomethylacrylic acid ethyl ester. 7-10, 17 and 22-27 have been synthesized for the first time. 相似文献
5.
Dr. D. Byron May Pharm.D.M Dr. Richard H. Drew M.S. Dr. Kimberly C. Yedinak Pharm.D. Dr. John A. Bartlett M.D. 《Pharmacotherapy》1994,14(5):509-513
Study Objective . To investigate the effect of simultaneously administered didanosine (ddI) on the absorption of a single dose of itraconazole. Design . Randomized, crossover, unblinded single-dose pharmacokinetic study in healthy volunteers. Comparisons of itraconazole alone and itraconazole with simultaneous ddI were performed on days 1 and 15. Setting . A university medical center. Patients . Seven healthy men and women. Six subjects (86%) completed the study; one was removed due to the development of a rash. Interventions . Volunteers received a single 200-mg oral dose of itraconazole or itraconazole with concomitant oral ddI 300 mg (two 150-mg tablets) dispersed in 240 ml water. Each regimen was separated by a 2-week washout period. Serum samples were obtained frequently for 12 hours after the dose. Measurements and Main Results . Concentrations of itraconazole were determined using a microbiologic assay. Individual concentrations in serum versus time data were evaluated by linear regression analysis. Peak serum concentration and time to peak were determined by visual inspection of each individual's serum concentration-time curve. A mean ± SD peak serum itraconazole concentration of 0.90 ± 0.30 μg/ml was observed at 3.0 ± 0.7 hours when itraconazole was administered alone, compared with undetectable levels in all patients during therapy with ddI. Conclusions . Simultaneous oral administration of ddI significantly decreases absorption of itraconazole. These drugs should not be administered concurrently. 相似文献
6.
Babak Kasravi MD Cheryl L. Reid MD Byron J. Allen MD 《Journal of the American Society of Echocardiography》2004,17(12):599-1316
Coronary artery fistula is often considered to be a benign and rare congenital anomaly. It is usually an incidental finding encountered during routine cardiac catheterization. We report a case of a patient presenting with endocarditis involving a large coronary artery fistula connecting an aneurysmal circumflex coronary artery to the coronary sinus. The diagnosis was initially made by echocardiography and confirmed by cardiac catheterization. In addition, we briefly discuss the literature on management of this coronary anomaly. 相似文献
7.
8.
9.
Zhenfeng Xu Dajoie R Croslan Adalynn E Harris Gregory D Ford Byron D Ford 《Journal of cerebral blood flow and metabolism》2006,26(4):527-535
We have previously shown that neuregulin-1 (NRG-1) protects neurons from ischemic brain injury if administered before focal stroke. Here, we examined the therapeutic window and functional recovery after NRG-1 treatment in rats subjected to 90 mins of middle cerebral artery occlusion (MCAO) and 24 h of reperfusion. Neuregulin-1 (2.5 ng/kg bolus, 1.25 ng/kg/min infusion) reduced infarct volume by 89.2%+/-41.9% (mean+/-s.d.; n=8; P<0.01) if administered immediately after the onset of reperfusion. Neuroprotection was also evident if NRG-1 was administered 4 h (66.4%+/-52.6%; n=7; P<0.01) and 12 h (57.0%+/-20.8%; n=8; P<0.01) after reperfusion. Neuregulin-1 administration also resulted in a significant improvement of functional neurologic outcome compared with vehicle-treated animals (32.1%+/-5.7%; n=9; P<0.01). The neuroprotective effect of the single administration of NRG-1 was seen as long as 2 weeks after treatment. Neurons labeled with the neurodegeneration marker dye Fluoro-JadeB were observed after MCAO in the cortex, but the numbers were significantly reduced after NRG-1 treatment. These results indicate that NRG-1 is a potent neuroprotective compound with an extended therapeutic window that has practical therapeutic potential in treating individuals after ischemic brain injury. 相似文献
10.